Notice for crisantaspase (Jazz Pharmaceuticals ANZ Pty Ltd)
Active ingredients
crisantaspase
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
JZP-458 is used in combination with other chemotherapeutic agents to treat patients with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LBL)
Therapeutic area
Haematology